Works matching IS 14248247 AND DT 2010 AND VI 3 AND IP 11
Results: 6
Jak2 Tyrosine Kinase: A Potential Therapeutic Target for AT<sub>1</sub> Receptor Mediated Cardiovascular Disease.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3478, doi. 10.3390/ph3113478
- By:
- Publication type:
- Article
Allosteric Modulation of αβδ GABA<sub>A</sub> Receptors.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3461, doi. 10.3390/ph3113461
- By:
- Publication type:
- Article
Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3435, doi. 10.3390/ph3113435
- By:
- Publication type:
- Article
Multiple Routes to Oestrogen Antagonism.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3417, doi. 10.3390/ph3113417
- By:
- Publication type:
- Article
Nanomedicine Faces Barriers.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3371, doi. 10.3390/ph3113371
- By:
- Publication type:
- Article
Inactivation of Anandamide Signaling: A Continuing Debate.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 11, p. 3355, doi. 10.3390/ph3113355
- By:
- Publication type:
- Article